In today’s recent session, 0.46 million shares of the Salarius Pharmaceuticals Inc (NASDAQ:SLRX) have been traded, and its beta is 0.89. Most recently the company’s share price was $1.80, and it changed around $0.28 or 18.61% from the last close, which brings the market valuation of the company to $2.60M. SLRX at last check was trading at a discount to its 52-week high of $7.20, offering almost -300.0% off that amount. The share price’s 52-week low was $1.22, which indicates that the recent value has risen by an impressive 32.22% since then. We note from Salarius Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 92980.0 shares, with the 3-month average coming to 329.95K.

Salarius Pharmaceuticals Inc (NASDAQ:SLRX) trade information

Instantly SLRX has been showing a green trend so far today with a performance of 18.61% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.0600 on recent trading dayincreased the stock’s daily price by 12.62%. The company’s shares are currently down -65.33% year-to-date, but still up 14.83% over the last five days. On the other hand, Salarius Pharmaceuticals Inc (NASDAQ:SLRX) is 26.07% up in the 30-day period. We can see from the shorts that 65040.0 shares have been sold at a short interest cover period of 0.08 day(s).

Salarius Pharmaceuticals Inc (NASDAQ:SLRX)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 2.52% of Salarius Pharmaceuticals Inc shares, and 0.36% of them are in the hands of institutional investors. The stock currently has a share float of 0.37%.